Results 81 to 90 of about 65,713 (156)

Adoptive Cell Transfer of Allogeneic Epstein-Barr Virus-Specific T Lymphocytes for Treatment of Refractory EBV-Associated Posttransplant Smooth Muscle Tumors: A Case Report. [PDF]

Front Immunol, 2021
Hansen BT, Bacher P, Eiz-Vesper B, Heckl SM, Klapper W, Koch K, Maecker-Kolhoff B, Baldus CD, Fransecky L.   +8 more
europepmc   +1 more source

Adoptive γδ T cell therapy controls cytomegalovirus infection in preclinical transplantation models

Nature Communications
γδ T cells show promise for anti-tumoral therapies but have yet to be evaluated to treat infectious diseases. In this preclinical study, we assess a Vδ1 + γδ T cell-based adoptive cell therapy, named Delta One T cells, to treat cytomegalovirus (CMV ...
Gabriel Marsères, Coline Gentil, Claire Tinevez, Maxime Courant, Anaïs Cosentino, Selma Cornillot-Clément, Victor Bigot, Vincent Pitard, Atika Zouine, Julien Izotte, Isabelle Garrigue, Valérie Prouzet-Mauleon, Béatrice Turcq, Dany Anglicheau, Edouard Forcade, Hannah Kaminski, Bruno Silva-Santos, Pierre Merville, Myriam Capone, Julie Déchanet-Merville, Lionel Couzi   +20 more
doaj   +1 more source

Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients. [PDF]

Cancer Immunol Immunother, 2021
Dréno B, Khammari A, Fortun A, Vignard V, Saiagh S, Beauvais T, Jouand N, Bercegay S, Simon S, Lang F, Labarrière N.   +10 more
europepmc   +1 more source

Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma. [PDF]

Oncoimmunology, 2021
Wei T, Leisegang M, Xia M, Kiyotani K, Li N, Zeng C, Deng C, Jiang J, Harada M, Agrawal N, Li L, Qi H, Nakamura Y, Ren L.   +13 more
europepmc   +1 more source

microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy. [PDF]

Cancer Immunol Immunother, 2021
Galore-Haskel G, Greenberg E, Yahav I, Markovits E, Ortenberg R, Shapira-Fromer R, Itzhaki O, Schachter J, Besser MJ, Markel G.   +9 more
europepmc   +1 more source

Addition of anti-TIM3 or anti-TIGIT Antibodies to anti-PD1 Blockade Augments Human T cell Adoptive Cell Transfer. [PDF]

Oncoimmunology, 2021
Martinez M, Kim S, St Jean N, O'Brien S, Lian L, Sun J, Verona RI, Moon E.   +7 more
europepmc   +1 more source

Salvage Metastasectomy After Adoptive Cell Transfer for Melanoma: Long-Term Updates. [PDF]

Ann Surg Oncol
Dinerman AJ, Gustafson AM, Hitscherich KJ, White DE, Krishna S, Schrump DS, Hoang CD, Hernandez JM, Gartner JJ, Robbins PF, Kwong ML, Goff SL, Yang JC, Rosenberg SA, Klemen ND.   +14 more
europepmc   +1 more source

Simultaneous gene engineering of T cells with multiple neoantigen-specific T cell receptors for adoptive cell transfer. [PDF]

Mol Ther Adv
Magna M, Levy L, Csomos K, Dinerman AJ, Hakim AA, Levin N, Kim SP, Zacharakis N, Parikh NB, Bui BD, Bhasin A, Beyer RK, Goff SL, Lowery FJ, Rosenberg SA, Krishna S.   +15 more
europepmc   +1 more source

Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma. [PDF]

J Immunother Cancer, 2021
Saberian C, Amaria RN, Najjar AM, Radvanyi LG, Haymaker CL, Forget MA, Bassett RL, Faria SC, Glitza IC, Alvarez E, Parshottam S, Prieto V, Lizée G, Wong MK, McQuade JL, Diab A, Yee C, Tawbi HA, Patel S, Shpall EJ, Davies MA, Hwu P, Bernatchez C.   +22 more
europepmc   +1 more source

Delineation and monitoring of the T cell repertoire of adoptive cell transfer product during the treatment of advanced melanoma. [PDF]

Genome Med
Kerr C, Soleimani S, Mulder DT, Nabbi A, Gray D, Pedersen S, Sotov V, Sudhaman S, Nguyen L, Hirano N, Ohashi PS, Butler MO, Pugh TJ.   +12 more
europepmc   +1 more source